A research team led by an award-winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.
These potentially game-changing technologies, developed by Peter Rogan, PhD, students and his collaborators from Western’s Schulich School of Medicine & Dentistry, reveal gene variants that were missed by conventional genetic testing.
